These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 8428405

  • 21. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Nov; 16(11):1357-69. PubMed ID: 9856375
    [Abstract] [Full Text] [Related]

  • 22. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG, Jain AK, Vargas R, Fillingim J.
    Clin Ther; 1990 Nov; 12(2):88-100. PubMed ID: 2191779
    [Abstract] [Full Text] [Related]

  • 23. Clonidine twice daily in hypertension. Effects of two dosage regimens on blood pressure, side-effects and plasma clonidine concentrations.
    Lilja M, Huikuri H, Jounela AJ, Juustila HJ, Paalzow G.
    Acta Med Scand; 1983 Nov; 214(2):111-7. PubMed ID: 6353878
    [Abstract] [Full Text] [Related]

  • 24. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J, Karas M, Nguyen P, Cartier P, Wistaff R, Toal CB, Nadeau R, Larochelle P.
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Randomized, double-blind comparison of transdermal clonidine with oral propranolol.
    Franklin SS, Tonkon MJ, Kirschenbaum MA, Dobak JD.
    J Cardiovasc Pharmacol; 1987 Sep; 10 Suppl 12():S244-7. PubMed ID: 2455188
    [Abstract] [Full Text] [Related]

  • 28. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 29. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M, Taniguchi M, Sato K, Ueda R, Dohi Y.
    Nephron Clin Pract; 2004 Sep; 97(2):c49-53. PubMed ID: 15218330
    [Abstract] [Full Text] [Related]

  • 30. Clonidine in unilateral renal artery stenosis and unilateral renal parenchymal disease--similar antihypertensive but different renin suppressive effects.
    Mathias CJ, Wilkinson AH, Pike FA, Sever PS, Peart WS.
    J Hypertens Suppl; 1983 Dec; 1(2):123-5. PubMed ID: 6400111
    [Abstract] [Full Text] [Related]

  • 31. Importance of volume factors in dialysis related hypertension.
    Lins RL, Elseviers M, Rogiers P, Van Hoeyweghen RJ, De Raedt H, Zachee P, Daelemans RA.
    Clin Nephrol; 1997 Jul; 48(1):29-33. PubMed ID: 9247775
    [Abstract] [Full Text] [Related]

  • 32. Transdermal clonidine in mild hypertension. A randomized, double-blind, placebo-controlled trial.
    Popli S, Daugirdas JT, Neubauer JA, Hockenberry B, Hano JE, Ing TS.
    Arch Intern Med; 1986 Nov; 146(11):2140-4. PubMed ID: 3535714
    [Abstract] [Full Text] [Related]

  • 33. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Blood pressure and heart rate variability in patients on conventional or sodium-profiling hemodialysis.
    Rubinger D, Backenroth R, Pollak A, Sapoznikov D.
    Ren Fail; 2008 Nov; 30(3):277-86. PubMed ID: 18350447
    [Abstract] [Full Text] [Related]

  • 36. Clonidine through the skin in the treatment of essential hypertension: is it practical?
    Groth H, Vetter H, Knüsel J, Boerlin HJ, Walger P, Baumgart P, Wehling M, Siegenthaler W, Vetter W.
    J Hypertens Suppl; 1983 Dec; 1(2):120-2. PubMed ID: 6599488
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the antihypertensive effect of TTS clonidine by multiple 24-hour automatic blood pressure monitoring.
    Mancia G, Parati G, Pomidossi G, Malaspina D, Colombo A, Camesasca C, Groppelli A, Casadei R, Zanchetti A.
    J Cardiovasc Pharmacol; 1987 Dec; 10 Suppl 12():S187-93. PubMed ID: 2455177
    [Abstract] [Full Text] [Related]

  • 38. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.
    Iino Y, Hayashi M, Kawamura T, Shiigai T, Tomino Y, Yamada K, Kitajima T, Ideura T, Koyama A, Sugisaki T, Suzuki H, Umemura S, Kawaguchi Y, Uchida S, Kuwahara M, Yamazaki T, Japanese Lasartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study Investigators.
    Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Sep; 124(9-10):246-50. PubMed ID: 9102857
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.